is bpc-157 legal for human use fda warning Peptide Trump's FDA May Soon Throw
Description
CAS 137525-51-0
The rationale for titrating upward over time, rather than starting at the target dose, mirrors the approach taken with other metabolic peptides: the goal is to identify the minimum effective dose for each individual while monitoring for tolerability
PMID: 6810951.
It is connected to gastric peptide biology, connective tissue research, angiogenesis, nitric oxide signalling, fibroblast activity and inflammatory marker control
